Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, focused on the development of oncology, immunology, and critical care therapies, announced that Intas Pharmaceuticals...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Calidi Biotherapeutics, a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, announced the appointment of Guy Travis Clifton, MD as Chief...
Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), ranging from target validation and antibody discovery through...
PharmaLogic Holdings, a leading contract development and manufacturing organization (CDMO) specializing in radiopharmaceuticals, announces that it will acquire a majority stake in Agilera Pharma from...
